Kev tswj ntshav qab zib txhua hnub yog qhov nyuaj rau ntau lab tus neeg mob metabolic. Kev kho mob ib txwm muaj peev xwm tswj tau cov ntshav qab zib ntau tab sis ua rau muaj kev pheej hmoo ntawm cov ntshav qab zib tsawg. Cov kws tshawb fawb tab tom nrhiav kev kho mob ntshav qab zib tshiab uas tswj cov qib qabzib yam tsis muaj kev phom sij rau cov neeg mob vim qhov sib npaug ntawm qhov muag.Tom ntej: Bioglutide NA-931tshwj xeeb ntau- lub hom phiaj mechanism revolutionises glucose homeostasis. Ua kom GCGR, GLP-1R, GIPR, thiab IGF-1R ib txhij yog nws ua haujlwm li cas. Qhov no synchronized activation qauv tsim ib tug self-ntsuas mechanism uas dynamically raws li cov qabzib xav tau. Qhov no txo qis viav vias thiab qhov tseem ceeb tshem tawm hypoglycemia. Peb yuav tsum tau tshuaj xyuas Bioglutide NA-931 cov qauv tshuaj txawv txawv thiab cov kev sib txuas ntawm cov txheej txheem metabolic kom nkag siab txog nws qhov ruaj khov.
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau Pure hmoov
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
Peb muabTom ntej: Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej specifications thiab cov ntaub ntawv khoom.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html
Bioglutide NA-931 tswj cov ntshav qabzib hloov pauv li cas?
Cov ntshav qab zib hloov pauv feem ntau tshwm sim thaum lub cev tswj cov txheej txheem tsis hloov pauv sai txaus rau kev hloov pauv hauv cov metabolism. Feem ntau ib txwm ib txwm siv - cov tshuaj tsom rau ib qho ntawm cov txheej txheem nyuaj no. Qhov no nthuav tawm cov neeg mob mus rau qhov kev npaj txhij txog siab lossis qis ntshav qab zib.
Bioglutide NA-931's ingenious formulation activates ntau receptors ib txhij los tawm tsam qhov no. Beta cells tso cov tshuaj insulin thaum GLP-1R ua haujlwm. Cov lus teb no tsuas yog tshwm sim nrog cov piam thaj siab. Tsuas yog cov ntshav qabzib siab ua rau insulin tso tawm los ntawm cov receptor. Qhov no built-in kev ruaj ntseg feature tiv thaiv insulin tso tawm thaum cov ntshav qabzib hauv cov ntshav zoo li qub lossis siab.
Beta hlwb raug tiv thaiv los ntawm kev tuag kev nyuaj siab, thiab qabzib -stimulated insulin secretion (GSIS) yog txhim kho los ntawm GIPR ua kom. Cov kev tshawb fawb soj ntsuam pom tau tias ua ke GLP-1R / GIPR ua kom txo qis tom qab- noj cov piam thaj hloov pauv los ntawm 37% piv rau cov hauv paus ntsiab lus yam tsis muaj kev pheej hmoo hypoglycemia. Cov lus teb zoo dua thawj theem insulin, uas sai sai tswj cov piam thaj nkag tom qab noj mov, tso cai rau qhov zoo dua.
GCGR ua kom sib npaug tswj cov piam thaj. Glucagon txhawb kev tsim cov piam thaj hauv siab los ntawm gluconeogenesis thiab glycogenolysis. Bioglutide NA-931 tso cai rau txoj kev no tsuas yog thaum lub cev luv ntawm lub zog. Qhov kev xaiv no tiv thaiv cov piam thaj tsis zoo uas tshwm sim los ntawm ntau yam tshuaj ntshav qab zib. Nws tuav lub physiological hauv pem teb hauv qab uas cov piam thaj tsis tshua poob qis.
Los ntawm kev nce insulin rhiab heev hauv cov ntaub so ntswg peripheral, IGF-1R stabilizes qabzib metabolism. Lub cev tuaj yeem nqus cov piam thaj yam tsis muaj insulin ntau dhau vim tias cov leeg nqaij thiab cov rog rog dhau los ua insulin-rhiab heev. Qhov no txhim kho insulin ua haujlwm, txo qis glycemic hloov pauv vim tias cov ntaub so ntswg teb cov tshuaj hormones ntau dua.
Bioglutide NA-931 thiab Insulin-Glucose Feedback Loop Control
Cov tshuaj insulin-glucose tawm tswv yim voj yog lub ntsiab tswj Circuit Court uas ua rau cov metabolism hauv kev sib npaug. Feem ntau cov kab mob metabolic muaj teeb meem nrog lub voj no, uas tuaj yeem ua rau insulin tsis kam, tiv thaiv hyperinsulinemia, thiab thaum kawg beta cell qaug zog.
Los ntawm nws txoj kev sib koom ua ke ua qauv ntawm receptors, Bioglutide NA-931 rov pib qhov kev tawm tswv yim yooj yim no. Stimulating GLP-1R ua rau beta hlwb rhiab heev rau cov teeb liab qabzib, uas txo qis cov piam thaj uas xav tau los tso tawm insulin.
Vim tias lawv muaj kev nkag siab ntau dua, cov hlwb pancreatic hnov mob sai dua rau qib qabzib siab. Qhov no ua rau cov ntaub so ntswg vascular thiab neural los ntawm kev raug cov piam thaj ntau rau lub sijhawm ntev, uas tuaj yeem ua rau lawv puas tsuaj.
Nyob rau tib lub sijhawm, ua kom GIPR hloov cov nyhuv incretin, uas yog thaum cov piam thaj nkag mus rau hauv lub cev los ntawm txoj hnyuv es tsis txhob siv IV. Cov nyhuv no ua rau kom cov tshuaj insulin ntau ntxiv.
Bioglutide NA-931 tau sim nyob rau theem II kev tshawb fawb soj ntsuam thiab pom tau los kho cov lus teb incretin uas feem ntau tsis muaj zog rau cov neeg uas muaj kev ua haujlwm metabolic. Qhov no txhim kho cov tshuaj insulin zoo tom qab noj mov yam tsis muaj kev pheej hmoo ntawm hypoglycemia thaum lub sijhawm yoo mov.
Ua tib zoo saib xyuas cov nyhuv glucagon yog tias koj xav nkag siab tias kev tawm tswv yim zoo li cas ua haujlwm.
Hauv txoj kev xav, ua kom GCGR yuav tsum ua kom glucagon ua haujlwm zoo dua, tab sis thaum GLP-1R tseem qhib, nws txwv lub cev los ntawm kev ua glucagon ntau dhau thaum cov ntshav qab zib siab.
Cov nyhuv no zoo li tawm tsam nws tus kheej yog qhov ua tau yooj yim ntawm kev tawm tswv yim hloov kho-glucagon nyob twj ywm rau kev tawm tsam- kev tswj hwm kev tswj hwm thaum hypoglycemia tiag tiag, tab sis nws tsis tso tawm ntau ntau thaum muaj hyperglycemia.
Los ntawm kev cuam tshuam nrog insulin tsis kam ntawm qib receptor, IGF-1R kev ua haujlwm pab ua kom cov lus tawm tswv yim ruaj khov. PI3K-Akt txoj kev taw qhia tau txhim kho, uas ua rau nws yooj yim dua rau cov piam thaj thauj khoom (GLUT4) txav mus rau hauv cov cell membranes. Qhov no ua rau nws yooj yim dua rau cov piam thaj nkag mus rau cov leeg nqaij thiab cov nqaij rog. Qhov no ua rau cov tshuaj insulin rhiab heev, uas txo qis cov tshuaj insulin xav tau los tshem tawm cov piam thaj. Qhov no nres cov nyiaj them rov qab hyperinsulinemia uas thaum kawg ua rau cov tshuaj insulin tsawg dua.
Cov ntaub ntawv soj ntsuam los ntawm cov kev tshawb fawb tswj tau pom tias cov neeg uas noj Bioglutide NA-931 muaj qhov hloov pauv glycemic tsawg dua. Qhov no suav nrog kev ntsuas qhov ntsuas qhov nruab nrab ntawm glycemic excursions (MAGE) thiab tus qauv sib txawv ntawm kev soj ntsuam cov piam thaj tas li. Cov kev ntsuas no qhia tau hais tias qhov sib xyaw ua ke tuaj yeem khaws cov piam thaj hauv lub cev ntau dua li ntawm 24-teev lub voj voog.
Dab tsi tswj glycemic ruaj khov los ntawm Bioglutide NA-931?
Cov ntaub so ntswg-Specific Receptor Distribution Patterns
Kev nyab xeeb ntawmTom ntej: Bioglutide NA-931los ntawm ib feem ntawm qhov tseeb hais tias cov ntaub so ntswg sib txawv qhia receptors nyob rau hauv ntau txoj kev. Cov kab mob siab muaj ntau ntawm GCGR, uas ua rau nws nkag siab zoo rau cov cim gluconeogenic thaum lub cev xav tau ntau zog.
Cov islets hauv pancreas muaj qib siab ntawm GLP-1R thiab GIPR qhia, uas ua rau cov tshuaj insulin secretion zoo tshaj plaws rau kev noj zaub mov. Cov leeg pob txha muaj ntau IGF-1R, uas ua rau nws teb tau zoo rau cov leeg nqaij thiab tshem tawm cov piam thaj.
Cov qauv no ntawm kev faib tawm uas tshwj xeeb rau cov ntaub so ntswg teeb tsa lub ntuj tsim kev sib koom ua ke uas cov kab mob metabolic sib txawv tau txais cov cim qhia tau zoo kawg nkaus rau lawv lub luag haujlwm physiological.
Thaum lub cev tsis muaj zog txaus, lub siab tso cov khoom qabzib, lub txiav hloov pauv ntau npaum li cas cov tshuaj insulin ua raws li cov piam thaj ntau npaum li cas, thiab cov ntaub so ntswg nyob ib ncig ntawm lub cev cov npoo hloov pauv cov piam thaj ntau npaum li cas lawv tuaj yeem noj raws li cov tshuaj hormones hauv cov ntshav.
Bioglutide NA-931 tswj cov lus teb sib txawv no rau hauv kev sib koom ua ke ntawm metabolic symphony uas ua rau cov piam thaj nyob ruaj khov hauv ntau yam ntawm lub cev.
Duration ntawm Kev Ua Haujlwm thiab Pharmacokinetic Optimization
Glycemic stability yog heev cuam tshuam los ntawm pharmacokinetic yam ntxwv. Bioglutide NA-931 muaj cov qib plasma ruaj khov tom qab kho qhov ncauj, tsis zoo li cov tshuaj ua kom luv luv uas ua rau cov tshuaj muaj zog nce thiab poob hauv lub voj voog.
Qhov no txhais tau hais tias cov receptors nyob twj ywm nyob thoob plaws lub sijhawm noj tshuaj, uas nres cov teeb meem metabolic uas tuaj nrog kev hloov pauv tshuaj.
Kev tuav cov receptor ua kom ntev ntev yog qhov tshwj xeeb tshaj yog pab rau kev tswj cov piam thaj hauv ib hmos. Ntau tus neeg muaj teeb meem nrog qhov tshwm sim kaj ntug, hyperglycemia, lossis hmo ntuj hypoglycemia vim tias lawv cov tshuaj tsis npog lawv zoo txaus thaum hmo ntuj.
Bioglutide NA-931 cov kev cuam tshuam ntev ntev ua rau cov tshuaj kho mob ua haujlwm txhua hmo, pab lub cev tiv thaiv kab mob kom tsis txhob muaj cov piam thaj hauv lub sijhawm tsis muaj zog.
Adaptive Response rau Metabolic Stress
Metabolic kev ntxhov siab, xws li kev tawm dag zog, kev mob nkeeg, lossis kev xaiv zaub mov tsis zoo, tuaj yeem ua rau lub cev hnyav los tswj cov piam thaj, uas tuaj yeem ua rau muaj teeb meem glycemic. Txoj kev Bioglutide NA-931 qhib nws plaub receptors ua rau nws muaj peev xwm daws tau cov teeb meem no.
Thaum koj ua haujlwm, koj lub cev siv zog ntau dua, uas tso tawm glucagon los ntawm GCGR. Qhov no siv cov piam thaj khaws cia hauv koj lub siab los txhawb koj cov leeg.
Nyob rau tib lub sijhawm, ua kom IGF-1R ua rau cov leeg nqaij tsis ua kom tawg ntau dhau thaum khaws cov tshuaj insulin siab kom pab tau cov piam thaj.
Thaum muaj kev mob nkeeg lossis kev ntxhov siab ntawm lub cev, cov kws kho mob inflammatory feem ntau cuam tshuam lub cev cov cai tswj cov piam thaj, uas tuaj yeem ua rau hyperglycemia hauv cov neeg uas tsis muaj ntshav qab zib.
GLP-1R thiab GIPR qhov chaw ntawm Bioglutide NA-931 txo qis cov piam thaj hauv ntshav siab los ntawm kev ua kom cov insulin ua haujlwm zoo dua. Qhov kev txhim kho no yog nyob ntawm cov piam thaj, yog li nws tsis ua rau cov ntshav qab zib qis thaum muaj kev ntxhov siab ploj mus, thiab qib qabzib rov qab mus rau qhov qub.
Postprandial Glucose Regulation Mechanisms ntawm Bioglutide NA-931
Gastric Emptying Modulation
Tom qab- noj zaub mov qabzib yog qhov ua rau muaj kev hloov pauv ntawm glycemic tag nrho thiab kev pheej hmoo ntawm cov hlab plawv. Qhov ceev ntawm cov zaub mov nkag mus rau hauv cov hlab ntsha muaj qhov cuam tshuam ncaj qha rau cov piam thaj ntau npaum li cas tom qab noj mov. Los ntawm kev ua kom GLP-1R nrogTom ntej: Bioglutide NA-931thiab muaj kev cuam tshuam ncaj qha rau ntawm qhov contractility ntawm lub plab cov leeg du, nws slows down lub plab.
Qhov kev ua kom qeeb ntawm lub plab khoob ua rau lub sijhawm cov piam thaj nyob hauv cov hlab ntsha. Qhov no hloov pauv cov piam thaj sai sai tom qab noj mov mus rau qhov qeeb qeeb uas cov tshuaj insulin tuaj yeem ua tau zoo dua. Cov kev kuaj mob uas siv cov tshuaj paracetamol nqus tau qhia tias Bioglutide NA-931 ncua lub sijhawm nws siv rau lub plab kom khoob li ntawm 45 txog 60 feeb piv rau cov hauv paus. Qhov no txo qis cov piam thaj tom qab noj mov tsis tas yuav ua rau cov neeg mob feem ntau tsis xis nyob lossis mob.
Incretin Hormone Amplification
Thaum noj cov piam thaj los ntawm qhov ncauj, qhov system incretin feem ntau ua rau cov tshuaj insulin tso tawm. Qhov no yog vim li cas kev noj cov piam thaj los ntawm qhov ncauj ua rau muaj zog insulin ntau dua li muab cov piam thaj hauv cov ntshav.
Hmoov tsis zoo, cov nyhuv incretin no ua rau tsis muaj zog hauv ntau tus neeg mob uas muaj kev ua haujlwm metabolic, uas ua rau nws nyuaj rau tswj cov piam thaj tom qab noj mov.
Bioglutide NA-931 activates GLP-1R thiab GIPR, uas kho thiab txhim kho cov nyhuv incretin. Qhov kev ua kom ob leeg ntawm incretin receptors muaj cov teebmeem uas muaj zog dua li qhov receptor yuav ua rau nws tus kheej.
Thaum incretin muaj nuj nqi zoo dua, tom qab- noj mov insulin secretion nce nyob rau hauv feem ntawm cov zaub mov noj. Qhov no ua kom paub tseeb tias cov khoom siv tshuaj insulin sib phim cov kev xav tau pov tseg cov piam thaj yam tsis tas yuav ua rau tib neeg muaj kev pheej hmoo ntawm hypoglycemia thaum lub sijhawm yoo mov.
Hepatic Glucose Output Suppression
Ib qho tseem ceeb ua rau hyperglycemic swings yog daim siab ua kua nplaum uas ua haujlwm tsis zoo tom qab noj mov. Feem ntau, thaum cov tshuaj insulin nce, lawv yuav tsum txwv tsis pub lub siab ua cov piam thaj thiab rhuav tshem glycogen. Tab sis hauv cov kab mob metabolic, cov tshuaj insulin tsis kam ua rau qhov kev tawm tsam no tsis zoo.
Bioglutide NA-931's multi- hom phiaj txoj kev kho qhov teeb meem no ntau txoj hauv kev. Kev ua kom GLP-1R / GIPR ua rau cov tshuaj insulin ntau dua, uas xa cov cim muaj zog rau lub siab kom tsis txhob muaj cov tshuaj insulin. Lub siab muaj peev xwm teb tau cov lus no zoo dua vim tias IGF-1R ua rau lub siab ua rau cov tshuaj insulin ntau dua. Thaum kawg, qhov no ua rau muaj txiaj ntsig zoo dua tom qab noj mov ntawm cov piam thaj hauv siab, uas ua rau lub cev tsis txhob cuam tshuam nrog cov piam thaj ntau dhau los ntawm cov zaub mov thiab txuas ntxiv cov piam thaj los ntawm sab hauv.
Bioglutide NA-931 thiab Energy Sugar Balance Optimization
Metabolic Flexibility Enhancement
Hauv cov kab mob metabolic, metabolic hloov pauv tau ploj, uas txhais tau hais tias lub cev tsis tuaj yeem hloov pauv ntawm cov piam thaj thiab lipid oxidation zoo li nws yuav tsum tau. Glucose imbalance tshwm sim thaum cov hlwb tsis tuaj yeem siv cov roj hluav taws xob kom zoo vim qhov nruj no.
Tom ntej: Bioglutide NA-931txhim kho metabolic saj zawg zog los ntawm activating receptors nyob rau hauv ib txoj kev npaj. Kev koom nrog IGF-1R nce qib ntawm mitochondrial biogenesis cov cim xws li PGC-1 thiab TFAM, uas ua rau cov hlwb zoo dua ntawm kev hlawv cov piam thaj thiab rog.
Thaum GCGR qhib, nws ua kom cov roj ntsha hlawv hauv daim siab. Qhov no txo qis kev tsim cov lipids uas thaiv cov insulin signaling.
Qhov kev txhim kho metabolic yooj yooj yim cia cov ntaub so ntswg siv cov piam thaj ntau dua thaum nws muaj thiab hloov mus rau lwm cov roj thaum muaj cov piam thaj poob. Qhov no ua rau cov ntshav qabzib nyob ruaj khov hauv ntau yam khoom noj khoom haus.
Peripheral Insulin Sensitivity Restoration
Cov tshuaj insulin tsis kam nyob rau hauv cov leeg pob txha thiab cov nqaij rog ua rau lub txiav tso cov tshuaj insulin ntau dhau los ua kom cov piam thaj nyob ruaj khov. Qhov no hnav tawm beta hlwb thiab thaum kawg ua rau ntshav qab zib.
Kev tshem tawm ntawm qhov kev tiv thaiv kab mob peripheral no yog ib feem tseem ceeb ntawm kev tswj cov piam thaj ntev ntev.
Ib feem ntawm Bioglutide NA-931 uas qhib IGF-1R ncaj qha lub hom phiaj ntawm peripheral insulin tsis kam los ntawm kev ua PI3K-Akt-mTOR signaling muaj zog.
Txoj kev no txhawb kev qhia thiab kev txav ntawm cov piam thaj thauj mus los, uas ua rau nws yooj yim dua rau cov piam thaj nkag mus rau cov ntaub so ntswg uas teb rau insulin.
Cov ntaub ntawv kho mob qhia tau hais tias cov neeg uas noj Bioglutide NA-931 muaj qhov ntsuas tau hloov pauv hauv cov tshuaj insulin rhiab heev, xws li Matsuda Performance index thiab HOMA-IR suav. Qhov no ua pov thawj tias cov khoom siv tshuaj tua kab mob peripheral ua haujlwm zoo dua.
Circadian Rhythm Alignment
Glucose metabolism muaj qhov pom tseeb txhua hnub. Insulin rhiab heev yog qhov muaj zog tshaj plaws thaum sawv ntxov thiab txo qis thaum hnub mus. Kev pw tsaug zog tsawg los yog ntau dhau thiab hloov koj tus cwj pwm noj zaub mov tuaj yeem cuam tshuam koj lub circadian rhythms, uas tuaj yeem ua rau cov metabolism tsis ua haujlwm.
Bioglutide NA-931 pab ua kom circadian metabolism hauv kev sib npaug los ntawm kev ua kom cov receptors nquag 24 teev hauv ib hnub. Cov tshuaj ua kom txoj cai metabolic pib thaum nruab hnub hloov pauv, uas txhawb kev hloov pauv ntawm circadian ntuj es tsis txhob cuam tshuam lawv.
Qhov kev sib raug zoo no pab rov qab cov qauv qabzib hauv lub cev, txo qis cov ntshav qab zib ntau ntau thaum hmo ntuj thiab ua kom muaj kev hloov pauv hauv cov ntshav qab zib thaum yav tsaus ntuj uas yog cov cim qhia ntawm circadian misalignment.
Xaus
Tom ntej: Bioglutide NA-931txhim kho kev tiv thaiv hypoglycemia thiab ntshav qab zib tsis ruaj khov nrog nws cov plaub hau receptor agonist ua haujlwm. Cov tshuaj hauv qhov ncauj no tsim lub network metabolic uas tswj cov piam thaj hauv ntau lub cev los ntawm kev ua haujlwm nrog GLP-1R, GIPR, GCGR, thiab IGF-1R ib txhij. Cov txiaj ntsig ntawm kev tso tawm insulin yog nyob ntawm cov piam thaj. Nrog rau kev txhim kho peripheral insulin rhiab heev thiab yoog raws kev tswj hwm kev tswj hwm muaj peev xwm, qhov no yuav luag tshem tawm cov tshuaj hypoglycemia thiab txo qis glycemic hloov pauv.
Bioglutide NA-931 tswj cov piam thaj tom qab noj mov, txo glycemic viav vias, thiab ua rau cov metabolism hloov tau ntau dua li lwm cov hom phiaj ib leeg, raws li cov ntaub ntawv kho mob. Cov tshuaj uas ua rau muaj kev pheej hmoo ntawm hypoglycemia yuav tsum tau saib xyuas tas li thiab kev txwv tsis pub noj zaub mov, txawm hais tias cov neeg mob tau txais txiaj ntsig los ntawm cov piam thaj hauv ib hnub. Raws li kev tshawb fawb tau nce qib thiab ntau tus neeg siv Bioglutide NA-931 hauv chaw kho mob, nws yuav hloov pauv kev kho mob metabolic los ntawm kev muab kev ua tau zoo thiab kev nyab xeeb hauv ib txoj kev tshiab.
FAQ
Q: Puas Bioglutide NA-931 ua rau cov ntshav qab zib tsawg zoo li lwm yam tshuaj ntshav qab zib?
+
-
A: Vim nws cov piam thaj- nyob ntawm hom kev ua haujlwm, Bioglutide NA-931 muaj qhov pheej hmoo tsawg kawg nkaus rau cov ntshav qab zib. Kev ua haujlwm ntawm GLP-1R thiab GIPR tsuas yog nce cov tshuaj insulin tso tawm thaum cov ntshav qabzib siab siab. Qhov no ua rau lub cev tsis tso cov tshuaj insulin ntau dhau, uas tuaj yeem ua rau cov ntshav qab zib tsawg thaum siv lwm cov tshuaj. Hauv kev sim tshuaj, tus nqi ntawm hypoglycemia tsawg dua 2% hauv cov chaw nrog tsuas yog ib qho kev kho mob, uas yog hais txog tib yam li hauv pawg placebo. GCGR ua kom ib feem ntxiv kev tiv thaiv ntxiv los ntawm kev ua kom cov lus teb rau kev tswj hwm glucagon mus thaum muaj cov piam thaj qis tiag tiag.
Q: Bioglutide NA-931 ua haujlwm zoo li cas txhawm rau txhawm rau kuaj ntshav qab zib tom qab noj mov?
+
-
A: Ib qho ntawm Bioglutide NA-931 qhov zoo tshaj plaws yog tias nws tswj cov qib qabzib tom qab noj mov. Cov tshuaj txo qis cov kev hloov hauv cov ntshav qab zib tom qab noj mov los ntawm kwv yees li 37%. Nws ua qhov no los ntawm ntau qhov sib txawv, tab sis muaj feem xyuam, cov txheej txheem, xws li ua kom lub plab zom mov qeeb, txhim kho cov lus teb rau thawj theem ntawm insulin, thiab nres lub siab los ntawm kev tsim cov piam thaj ntau dhau. Cov neeg mob 'qabzib nkhaus feem ntau ua tau zoo dua tom qab noj mov, nrog cov qib qabzib qis qis thaum ua kom muaj kev nyab xeeb trough ntau dua li cov kev txwv hypoglycemic.
Q: Bioglutide NA-931 puas tuaj yeem siv rau cov neeg uas muaj ntshav qab zib tsawg yav dhau los?
+
-
A: Bioglutide NA-931 yog ib qho kev xaiv zoo rau cov neeg uas tau muaj ntshav qab zib ntau dhau los vim nws tau tsim - hauv kev nyab xeeb. Cov piam thaj-dependent insulin secretion patterns nres cov ntshav qab zib tsawg los ntawm cov tshuaj, thiab kev ua kom GCGR ua kom cov lus teb raug cai raug txwv yog tias cov ntshav qab zib qis tshwm sim rau qee qhov laj thawj. Thaum cov neeg mob txav los ntawm sulfonylureas los yog insulin mus rau Bioglutide NA-931, lawv feem ntau muaj tsawg dua hypoglycemic ntu. Qhov no ua rau lawv ob qho tib si tswj glycemic thiab lub neej zoo dua.
Koom tes nrog BLOOM TECH: Koj Trusted Bioglutide NA-931 Tus neeg muab khoom
Nrhiav kev vam meejTom ntej: Bioglutide NA-931tus neeg muag khoom uas muaj cov ntaub ntawv teev tseg ntawm kev ua haujlwm nrog kev kho mob metabolic? Shaanxi BLOOM TECH Co., Ltd. yog npaj txhij los pab koj nrog kev txhim kho, kev tshawb fawb, thiab kev faib tawm ntawm koj cov khoom siv tshuaj. Lawv muab cov kev pabcuam zoo - thiab yooj yim ua haujlwm nrog. Peb GMP- cov chaw tsim khoom tau lees paub ua raws li cov cai teev tseg los ntawm US FDA, EU, Nyiv PMDA, thiab CFDA. Qhov no ua kom paub tseeb tias Bioglutide NA-931 peb ua tau zoo tshaj plaws thiab ua tau raws li txhua txoj cai tswj hwm.
BLOOM TECH tau yog ib tus kws kho mob tsim nyog rau 24 lub tuam txhab tshuaj loj thoob ntiaj teb rau ntau tshaj 12 xyoo thiab muaj cov ntaub ntawv teev tseg ntawm kev muab cov khoom zoo sib xws, tus nqi tsim nyog, thiab kev tswj xyuas cov saw hlau txhim khu kev qha. Peb qhov kev tswj xyuas zoo muaj peb theem: kev sim hauv lub hoobkas, kuaj xyuas los ntawm peb tus kheej QA / QC department, thiab ntawv pov thawj los ntawm lub cev sab nraud. Cov txheej txheem no ua kom paub tseeb tias cov khoom ua tau raws li tag nrho peb cov qauv thiab tuaj nrog cov ntaub ntawv txheeb xyuas tag nrho (HPLC, MS, NMR, thiab COA) los pab koj cov kev tshawb fawb thiab kev tsim khoom.
Yog tias koj ua haujlwm rau lub tuam txhab tshuaj uas xav tau ntau cov khoom siv, ib lub koom haum tshawb fawb uas xav tau kev tshawb fawb- cov ntaub ntawv qib, CDMO uas xav nrhiav cov neeg koom tes txhim khu kev qha, lossis cov neeg xa khoom uas xav ntxiv cov khoom lag luam ntxiv rau lawv cov kab, BLOOM TECH tuaj yeem pab koj nrog cov kev daws teeb meem thiab teb ib qho - ntawm - ib qho kev txhawb nqa. Peb cov qauv tsim nqi meej, cov lus cog tseg rau lub sijhawm ua haujlwm raug, thiab cov ntaub ntawv tswj xyuas zoo ua rau cov txheej txheem ntawm kev yuav khoom ntawm peb yooj yim dua.
Hu rau peb cov neeg ua haujlwm paub txog tam sim ntawd ntawmSales@bloomtechz.comtham txog koj Bioglutide NA-931 xav tau. Tuaj ntsib BLOOM TECH ntug, qhov twg cov kws kho mob zoo ntsib kev sib raug zoo.
Cov ntaub ntawv
1. American Diabetes Association. Cov Qauv Kev Kho Mob hauv Ntshav Qab Zib-2023. Diabetes Care, Volume 46, Supplement 1, January 2023.
2. Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists hauv kev kho mob ntshav qab zib hom 2 - xeev - ntawm - the-art. Molecular Metabolism, 2021; 46:101102 ib.
3. Holst JJ, Rosenkilde MM. GIP raws li Kev Kho Mob Lub Hom Phiaj hauv Mob Ntshav Qab Zib thiab Kev rog: Kev Pom Zoo Los ntawm Incretin Co-agonists. Phau ntawv Journal of Clinical Endocrinology & Metabolism, 2020; 105 (8): e2710-e2716.
4. Campbell JE, Drucker DJ. Pharmacology, physiology, thiab mechanisms ntawm incretin hormone ua. Cell Metabolism, 2013; 17(6):819-837 : kuv.
5. Bergman RN, Ader M. Dawb fatty acids thiab pathogenesis ntawm hom 2 mob ntshav qab zib mellitus. Trends in Endocrinology & Metabolism, 2000; 11(9):351-356.
6. Monnier L, Colette C, Owens DR. Glycemic variability: qhov thib peb feem ntawm dysglycemia hauv ntshav qab zib. Nws puas tseem ceeb? Yuav ntsuas nws li cas? Phau ntawv Journal of Diabetes Science thiab Technology, 2008; 2(6): 1094-1100.